4.4 Article

Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities

Journal

ANTI-CANCER DRUGS
Volume 22, Issue 1, Pages 35-45

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CAD.0b013e32833fde29

Keywords

apoptosis; cell cycle; colon cancer; protopanaxadiol derivatives; semisynthesis

Funding

  1. NIH/NCCAM [P01 AT004418, R21 AT003255, K01 AT005362]
  2. NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418, K01AT005362] Funding Source: NIH RePORTER
  3. NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003255] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protopanaxadiol (PPD), an aglycon of ginseng saponins, has shown anticancer activity in earlier studies. Here, we have reported the semisynthesis of nine PPD derivatives with acetyl substitutions. Subsequently, the antiproliferative effects of these nine analogs on different human cancer cell lines have been investigated. Compounds 1, 3, and 5 showed more significant and more potent antiproliferative activity compared with PPD and other derivatives. A flow cytometric assay indicated that compounds 1, 3, and 5 arrested cell cycle progression in the G1 phase and significantly induced apoptosis of cancer cells. Anti-Cancer Drugs 22: 35-45 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available